Ranolazine
NDC 63304-018, Ranolazine, tablet, extended release, from Sun Pharmaceutical Industries, Inc..
- Product NDC
- 63304-018
- Status
- Listed
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211707
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63304-018 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RANOLAZINE1000 mg/1
Pharmacologic classes
Anti-anginal [EPC]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Organic Cation Transporter 2 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63304-018-05 | 63304001805 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-018-05) |
| 63304-018-28 | 63304001828 | 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-018-28) |
| 63304-018-60 | 63304001860 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-018-60) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/c5848232-b7fd-4fe5-a543-16d6c4b5c0b1
Use it
Look up 63304-018 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63304-018 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63304-018. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.